Development of Cancer Drugs for Use in Novel Combination – Determining the Contribution of the Individual Drugs’ Effects

CGMP/Active Pharmaceutical Ingredient (API)/Adulterated/Misbranded

Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet

FDA’s CDER Small Business and Industry Assistance (SBIA) is making available our YouTube learning library – now hundreds of our recordings are readily accessible.

CDER has established a meeting program called the Emerging Drug Safety Technology Meeting (EDSTM) program. Learn more.

The U.S. Food and Drug Administration today announced 9 voucher recipients under the new Commissioner’s National Priority Voucher (CNPV) pilot program.

The Compounding Quality Center of Excellence’s free in-person training programs target outsourcing facility staff and offer continuing education credits. The training will open for state regulators and pharmacy compounders if space is available.